Raynaud's phenomenon in a child with medulloblastoma as a late effect of chemotherapy

Journal of Cancer Research and Therapeutics

Volumn 11, Issue 3, 2015, Pages 666-

  Atas, Erman ^a   Korkmazer, Nadir ^a   Artik, Hatice A ^b   Babacan, Oguzhan ^a   Kesik, Vural ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Yildirim Beyazit Training and Research Hospital   (Turkey)

Author keywords

Chemotherapy; late effect; Raynaud's phenomenon

Indexed keywords

CISPLATIN; IMMUNOGLOBULIN G; LOMUSTINE; PARACETAMOL; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADOLESCENT; ANALGESIA; ARTICLE; ATAXIC GAIT; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CHILDHOOD CANCER; COMPUTER ASSISTED TOMOGRAPHY; CYANOSIS; DIZZINESS; ERYTHEMA; EXCISION; FEMALE; FINGER; GIRL; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; HYPOTHYROIDISM; MEDULLOBLASTOMA; MOTOR DYSFUNCTION; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEUROIMAGING; OSTEOPOROSIS; PAIN; PALLOR; PHYSICAL EXAMINATION; RAYNAUD PHENOMENON; SPEECH DISORDER; TOE; VOMITING; CEREBELLAR NEOPLASMS; CHEMICALLY INDUCED; CHEMORADIOTHERAPY; RAYNAUD DISEASE; VASCULARIZATION;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CEREBELLAR NEOPLASMS; CHEMORADIOTHERAPY; CISPLATIN; FEMALE; FINGERS; HUMANS; LOMUSTINE; MEDULLOBLASTOMA; RAYNAUD DISEASE; TOES; VINCRISTINE;

EID: 84945120264     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.144649     Document Type: Article

References (9)

1. Hudson MM, Mertens AC, Yasui Y, Hobbie W, Chen H, Gurney JG, et al. Health status of adult long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. JAMA 2003;290:1583-92.
2. Oeffinger KC, Hudson MM. Long-term complications following childhood and adolescent cancer: Foundations for providing risk-based health care for survivors. CA Cancer J Clin 2004;54:208-36.
3. Guillot B, Bessis D, Dereure O. Mucocutaneous side effects of antineoplastic chemotherapy. Expert Opin Drug Saf 2004;3:579-87.
4. Doll DC, Ringenberg QS, Yarbro JW. Vascular toxicity associated with antineoplastic agents. J Clin Oncol 1986;4:1405-17.
5. Vogelzang NJ, Bosl GJ, Johnson K, Kennedy BJ. Raynaud's phenomenon: A common toxicity after combination chemotherapy for testicular cancer. Ann Intern Med 1981;95:288-92.
6. Fossa SD, Lehne G, Heimdal K, Theodorsen L. Clinical and biochemical long-term toxicity after postoperative cisplatin-based chemotherapy in patients with low-stage testicular cancer. Oncology 1995;52:300-5.
7. Toumbis-Ioannou E, Cohen PR. Chemotherapy-induced Raynaud's phenomenon. Cleve Clin J Med 1994;61:195-9.
8. Vogelzang NJ, Torkelson JL, Kennedy BJ. Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin. Cancer 1985;56:2765-70.
9. Adoue D, Arlet P, Vilain C, Le Tallec Y, Bonafe JL, de Lafontan B. Raynaud's phenomenon after chemotherapy. Apropos of 3 cases. Ann Dermatol Venereol 1985;112:151-5.